Cargando…
The antipsychotic potential of cannabidiol: clinical implications for patients with psychosis and comorbid cannabis use disorder
Autores principales: | Garel, Nicolas, Greenway, Kyle T., Joober, Ridha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Joule Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955839/ https://www.ncbi.nlm.nih.gov/pubmed/33464779 http://dx.doi.org/10.1503/jpn.200114 |
Ejemplares similares
-
Serotonin syndrome: SSRIs are not the only culprit
por: Garel, Nicolas, et al.
Publicado: (2021) -
Utilizing pharmacogenetics when treating first episode psychosis
por: Korchia, Theo, et al.
Publicado: (2023) -
Mindfulness-based intervention for benzodiazepine deprescription in hemodialysis patients with anxiety and depressive symptoms
por: Garel, Nicolas, et al.
Publicado: (2023) -
Population pharmacokinetics and dosing of long-acting injectable antipsychotics
por: Kim, David D., et al.
Publicado: (2021) -
Clinical management of psychosis in 22q11.2 deletion syndrome
por: Iftimovici, Anton, et al.
Publicado: (2022)